2315 — Biocytogen Pharmaceuticals Beijing Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapHigh Flyer

Market Cap
HK$4.66bn
Enterprise Value
HK$4.87bn
Revenue
CNY980.45m

Annual balance sheet for Biocytogen Pharmaceuticals Beijing Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	897	566	611	408	381
Net Total Accounts Receivable
Net Total Receivables	81.9	118	112	148	241
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,148	874	919	723	817
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,136	1,391	1,599	1,451	1,349
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,327	2,303	2,800	2,449	2,415
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	328	447	606	578	535
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	873	1,056	1,654	1,664	1,581
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	1,453	1,247	1,146	786	834
Total Liabilities & Shareholders' Equity	2,327	2,303	2,800	2,449	2,415
Total Common Shares Outstanding